These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3433915)

  • 1. Protective effectiveness of an endotoxin-depleted pertussis vaccine.
    Bannatyne RM; Jackowski J
    Vaccine; 1987 Dec; 5(4):268-9. PubMed ID: 3433915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the endotoxic activity of pertussis vaccine.
    Bannatyne RM; Cheung R
    J Hyg (Lond); 1981 Dec; 87(3):377-81. PubMed ID: 7310121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleaning up pertussis vaccine.
    Bannatyne RM; Jackowski J; Cheung R
    Vaccine; 1986 Jun; 4(2):91-2. PubMed ID: 3727760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effect of polymyxin B on pertussis vaccine.
    Larter WE; Corrigan JJ; Fulginiti VA
    Am J Dis Child; 1984 Mar; 138(3):281-3. PubMed ID: 6322572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attempts at analysis of toxicity of pertussis vaccine. III. Effects of endotoxin on leukocytosis in mice due to lymphocytosis-promoting factor and reference preparations for determination of lymphocytosis-promoting factor.
    Kurokawa M; Ishida S; Asakawa S; Iwasa S
    Jpn J Med Sci Biol; 1978 Apr; 31(2):91-103. PubMed ID: 682388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of active pertussis toxin may aid a pertussis vaccine to pass the mouse body weight gain test.
    Horiuchi Y; Takahashi M; Asada S; Ishida S
    Biologicals; 1994 Sep; 22(3):243-8. PubMed ID: 7811458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM; Lustigman B
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis vaccine: mouse-weight-gain (toxicity) test.
    Cameron J
    Dev Biol Stand; 1977; 34():213-5. PubMed ID: 838146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hyperreactivity to endotoxin on the toxicity of pertussis vaccine and pertussis toxin in mice.
    Sidey FM; Furman BL; Wardlaw AC
    Vaccine; 1989 Jun; 7(3):237-41. PubMed ID: 2781857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of monolaurates for removing endotoxins from preparations of cell-free pertussis vaccine].
    Perel'man EV; Bulk VF; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (7-8):37-9. PubMed ID: 1466170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempts at analysis of toxicity of pertussis vaccine. I. Body weight-decreasing toxicity in mice.
    Kurokawa M; Ishida S; Iwasa S; Asakawa S; Kuratsuka K
    Jpn J Med Sci Biol; 1968 Apr; 21(2):137-53. PubMed ID: 4299576
    [No Abstract]   [Full Text] [Related]  

  • 12. The detoxification of Bordetella pertussis with glutaraldehyde.
    Iida T; Horiuchi Y
    J Biol Stand; 1987 Jan; 15(1):17-26. PubMed ID: 2881932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempts at analysis of toxicity of pertussis vaccine. II. Quantitative determination of the heat-labile toxin by skin reaction.
    Kurokawa M; Ishida S; Asakawa S
    Jpn J Med Sci Biol; 1969 Oct; 22(5):293-307. PubMed ID: 4312799
    [No Abstract]   [Full Text] [Related]  

  • 14. Endotoxin-induced hypersensitivity to histamine in mice. I. Contrasting effects of bacterial lipopolysaccharides and the classical histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Bacteriol; 1966 Jun; 91(6):2169-74. PubMed ID: 5943934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of antipertussis vaccine].
    Desbordes J; Suire A
    Prog Immunobiol Stand; 1970; 4():592-6. PubMed ID: 5482200
    [No Abstract]   [Full Text] [Related]  

  • 16. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse breeds and the toxicity test for pertussis vaccine.
    Pittman M
    Dev Biol Stand; 1980; 45():129-35. PubMed ID: 7399144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines.
    Xing DK; Das RG; Williams L; Canthaboo C; Tremmil J; Corbel MJ
    Vaccine; 1999 Feb; 17(6):565-76. PubMed ID: 10075163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.